Startup | May 18, 2022
Mental wellness startup Lissun targets phygital presence in over 25 cities this year
The centres will be located in Tier I and Tier II cities
The centres will be located in Tier I and Tier II cities
The curriculum has been curated for General Physicians working in Clinikk
Viralex (Inosine Pranobex) is an immunomodulatory agent with broad-spectrum antiviral properties
Multiples is the first private equity (PE) investor in the company
Potential new treatment for progressive pulmonary fibrosis (PPF) builds on Boehringer Ingelheim’s leadership in lung fibrosis and will be further investigated in a phase III clinical trial program
WHO and UNICEF call on governments, industry, donors and civil society to fund and prioritize access to assistive products
As part of the celebrations, the Institute organised a series of activities in the run up to International Nurses Day which is observed on 12th May every year
The licences will allow manufacturers from around the world to work with MPP and C-TAP to make these technologies accessible to people living in low- and middle-income countries
AKS-452 is currently undergoing Phase II/III clinical testing in India as a primary vaccine; submission for Emergency Use Authorization (EUA) expected by Q3 2022
NextSWAB is currently optimized for nasal sample collection with validation for other sample types ongoing
Subscribe To Our Newsletter & Stay Updated
